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Protein tyrosine O-sulfation (PTS) plays a crucial role in extracellular biomolecular interactions that dictate various cellular processes. It also involves in the development of many
human diseases. Regardless of recent progress, our current understanding of PTS is still in its
infancy. To promote and facilitate relevant studies, a generally applicable method is needed to
enable efﬁcient expression of sulfoproteins with deﬁned sulfation sites in live mammalian
cells. Here we report the engineering, in vitro biochemical characterization, structural study,
and in vivo functional veriﬁcation of a tyrosyl-tRNA synthetase mutant for the genetic
encoding of sulfotyrosine in mammalian cells. We further apply this chemical biology tool to
cell-based studies on the role of a sulfation site in the activation of chemokine receptor
CXCR4 by its ligand. Our work will not only facilitate cellular studies of PTS, but also
paves the way for economical production of sulfated proteins as therapeutic agents in
mammalian systems.
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irst reported in 19541, protein tyrosine O-sulfation (PTS)
entails the transfer of a sulfate group from 3′-phosphoadenosine 5′-phosphosulfate (PAPS) to a protein tyrosine
residue under the catalysis of membrane-bound tyrosylprotein
sulfotransferases (TPSTs) in the trans-Golgi. It is considered the
most common type of tyrosine modiﬁcation in nature and occurs
exclusively on secreted and membrane-bound proteins that
transit the trans-Golgi network2–7. The introduction of negatively
charged sulfate groups plays a crucial role in extracellular biomolecular interactions that dictate various cellular processes,
including cell adhesion, leukocyte trafﬁcking, hormone activities,
and immune responses3–5,8. Tyrosine-sulfated proteins (referred
hereafter as sulfoproteins) are also involved in the development of
various infectious diseases (e.g., AIDS and malaria), cancers,
and immune-mediated diseases (e.g., allergy and rheumatoid
arthritis)9–15. Hence, PTS could emerge as an important therapeutic target for the treatment of human diseases. However, in
comparison to protein tyrosine phosphorylation, much of the
fundamental questions of PTS remain unanswered. Indeed, the
lack of understanding on the role of PTS in mammalian cell
biology severely hindered the efforts to unravel potential link(s)
between PTS and human diseases.
The key to a successful functional study of a PTS event is the
ability to synthesize site-speciﬁcally sulfated proteins. Although
sulfoproteins or sulfopeptides (fused to secreted proteins) can be
synthesized in eukaryotic cells with normal16–19 or
enhanced11,20,21 TPST activities, this method lacks the resolution
that is required to investigate a speciﬁc tyrosine O-sulfation event
within a protein containing multiple sulfotyrosine (sTyr) residues.
As such, chemically synthesized sulfopeptides22–25, became an
important tool to model the structural and functional role of
PTS5. Regardless of recent progress5,26, the preparation of sTyrcontaining peptides is still challenging. Furthermore, sulfopeptides may not faithfully resemble the native conformation and
biological function of full-length sulfoproteins. To meet above
challenges, the genetic incorporation of sTyr into proteins in
response to amber nonsense codon (TAG) was reported27. This
method enables the synthesis of site-speciﬁcally sulfated proteins
in Escherichia coli (E. coli) using engineered Methanocaldococcus
jannaschii tRNA (MjtRNATyr) and its cognate, sTyr-speciﬁc
tyrosyl-tRNA synthetase (sTyrRS) pair. However, the reported
MjtRNATyr-sTyrRS pair is limited to E. coli host and cannot be
used in mammalian cells where protein sulfation happens and
plays important biological roles. While our manuscript was under
preparation, Chatterjee et al. published an elegant work on the
genetic incorporation of sTyr in mammalian cells28.
Here we report the synthesis of site-speciﬁcally sulfated proteins in both live yeast and mammalian cells through the genetic
incorporation of sTyr using an engineered tyrosyl-tRNA synthetase derived from E. coli (EcTyrRS). Unlike the recently published work by Chatterjee et al.28, our engineering of EcTyrRS is
conducted by using yeast as the selection host. Although E. coli is
a more widely adopted platform in the directed evolution of
aminoacyl-tRNA synthetases (aaRSs), yeast has the translational
machinery that is more similar to that of the mammalian cells.
Besides an indirect ﬂuorescence-based assay in live cells and mass
spectrometry analysis, we also conduct in vitro enzyme assays
that provide direct activity proﬁles of evolved sTyrRSs. In order to
understand the shifted substrate speciﬁcity, we obtain a crystal
structure of the evolved sTyrRS in complex with sTyr, which also
shed lights on future engineering of the enzyme for substrates
with similar physicochemical properties. Finally, we perform a
cellular and functional study of a co-translationally synthesized
sulfoprotein in live mammalian cells. The study focuses on the
role of PTS in chemokine signaling, which is central to chronic
inﬂammatory conditions and is associated with the development
2

of many human diseases. In addition to fundamental biochemical
studies, this work also opens a door to the production of sulfoproteins as therapeutic agents in eukaryotes.
Results
Library construction and selection. The crystal structure of E.
coli tyrosyl-tRNA synthetase (EcTyrRS) in complex with Ltyrosine (PDB ID: 1X8X)29 was chosen in an initial protein
modeling effort to identify key residues that may lead to shifted
substrate speciﬁcity. We ﬁrst rebuilt the ligand in the active site
by adding a sulfate group to the hydroxyl group of tyrosine. The
simulation revealed that four active site residues (Y37, L71,
W129, and D182; Supplementary Fig. 1a) engaged in unfavorable
interactions with the new ligand. These four residues were
selected for the construction of an EcTyrRS mutant library.
Amino acid sequence at each of the four positions were fully
randomized using the NNK codon (N=A, C, T, or G, K=T or G;
32 variants at nucleotide level) in mutagenic overlap PCR reactions. Full-length mutant EcTyrRS genes were inserted behind an
ADH1 promoter in a pEcTyrRS-lib vector, which also encoded an
amber suppressor tRNA derived from E. coli tyrosyl-tRNA
(EctRNACUA). Using the yeast homologous recombination cloning method30, a library of 1 × 107 clones was obtained, which
represented an over 99% coverage of the theoretical library
diversity31. The quality of the obtained library was veriﬁed by
DNA sequencing (Supplementary Fig. 1b).
Selection of sTyr-speciﬁc EcTyrRS variants adapted an approach
that was previously established in Saccharomyces cerevisiae
(Supplementary Fig. 1c)32–34. The selection host MaV203 contained
chromosomal modiﬁcations that allowed the expression of a
reporter enzyme, URA3, under the regulation of the transcriptional
activator GAL4, which was encoded by a mutant gene containing
amber codons at positions 44 and 110. Plasmid DNA of the
EcTyrRS library was transformed into MaV203 together with the
GAL4-encoding plasmid, pGADGAL432. In a positive selection,
yeast cells were cultured in the presence of sTyr (1 mM). Effective
amber suppression by EcTyrRS mutants that can charge the amber
suppressor EctRNACUA with sTyr or any one of the 20 natural
amino acids enabled the growth of MaV203 host on media without
uracil supplementation. In a negative selection, yeast cells were
cultured in the absence of sTyr. Undesirable aminoacylation of
EctRNACUA by EcTyrRS mutants with natural amino acids led to
the conversion of exogenously added 5-ﬂuoroorotic acid (5-FOA,
0.1%) into a cytotoxic compound and caused cell death. A total of
1 × 107 library cells was subjected to positive selection. Survived cells
were then applied to the negative selection. Single colonies resulting
from the two rounds of selection were further replicated on
screening plates to verify sTyr-dependent growth in the absence of
uracil and good cell ﬁtness in the presence of 5-FOA. Four clones
were conﬁrmed to have the correct phenotype. DNA sequencing
revealed two unique mutants (c1 and c2 in Fig. 1a). Positions Leu71
and Asp182 showed a complete convergence to Val and Gly,
respectively, in both mutants. While Tyr37 did not change, position
Trp129 either maintained the wild-type sequence or changed to Phe.
Characterization of candidate sTyr tRNA synthetases (sTyrRSs).
We ﬁrst evaluated the activity of obtained sTyrRS candidates by
measuring amber suppression efﬁciency in yeast cells. Isolated
library plasmids encoding c1 or c2 were transformed into host
strain MaV203 together with a reporter plasmid, pyeGFPN149TAG, which harbored a yeast enhanced green ﬂuorescent
protein gene (yeGFP) with an amber mutation at the N149
position. The ﬂuorescence intensity of yeGFP was compared
when cells were cultured without or with sTyr (Fig. 1b). The two
sTyrRS variants led to similar levels of background ﬂuorescence
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Fig. 1 Characterization of sTyrRS candidates. a Mutations in the evolved sTyrRS variants. Numbers in parentheses represent the occurrence of the variant
from the selection. b Fluorescence readings of yeast cells expressing the evolved sTyrRSs and an yeGFP mutant that contained an amber mutation at
position N149. sTyr was included in culture media at 0 mM (open bar), 1 mM (ﬁlled orange bar), or 5 mM (ﬁlled red bar). Fluorescence intensity was
normalized to cell growth. c Initial velocities of pyrophosphate release by sTyrRS variants in the presence of Tyr and sTyr. Tyr was included in assays at 0.1
mM (ﬁlled gray bar) or 1 mM (ﬁlled yellow bar). sTyr was included in assays at 0.1 mM (ﬁlled dark gray bar) or 1 mM (ﬁlled orange bar). Assays were
carried out in the presence of 10 μM recombinant EctRNACUA. n.d., not detected. b, c Data are plotted as the mean ± standard deviation (s.d.) from n = 3
independent experiments. b, c Source data are provided as a Source data ﬁle.

in the absence of sTyr and comparable yeGFP expression in the
presence of 5 mM sTyr. The suppression of the amber codon in
pyeGFP-N149TAG suggested that both c1 and c2 were able to
aminoacylate EctRNACUA with sTyr in yeast. Furthermore,
ﬂuorescence in cells expressing c2 reached saturation at 1 mM of
sTyr (Fig. 1b), which indicated better substrate recognition.
To further compare the biochemical properties of the two
sTyrRS variants, we characterized them by in vitro assays. Each
enzyme was expressed and puriﬁed as a fusion protein with a
6xHis tag on the C terminus. Such modiﬁcation has previously
been reported to have a negligible effect on the function of the
wild-type EcTyrRS35. The aminoacyl-tRNA synthetase activities
were measured by monitoring the release of pyrophosphate in the
amino acid activation step of the tRNA acylation reaction36.
The assays were carried out in the presence of Tyr or sTyr as the
substrate (Fig. 1c). The c1 variant showed similar level of
activities on the two substrates at both 0.1 mM and 1 mM.
Meanwhile, the c2 variant was more speciﬁc for sTyr. At the same
concentration of 0.1 mM, the enzyme had no detectable activity
on Tyr, but was active on sTyr. It also showed a fourfold higher
activity on sTyr than Tyr when the substrate concentrations were
increased to 1 mM. Overall, the c2 variant had better substrate
speciﬁcity and maintained similar level of activities towards sTyr
as c1. It was chosen as the sTyrRS in following studies.
Evaluation of sTyrRS in mammalian cells. We examined the
evolved sTyrRS for its ability to incorporate sTyr in mammalian
cells using a two-plasmid method. The sTyrRS-encoding gene was
inserted behind a non-regulated CMV promoter on plasmid
psTyrRS, which has one copy of the amber suppressor tRNA
under the control of a human U6 promoter. The reporter plasmid, pEGFP37, contains an EGFP gene with an amber mutation
at the Y40 position and DNA sequence that encoded a Cterminus 6xHis tag. The selective incorporation of sTyr into
proteins was tested in 293 T cells that were transiently transfected
with plasmids psTyrRS and pEGFP. Following 24 h of incubation
in media without and with sTyr (1 mM), the amber suppression
level was studied by visualizing the expression of ﬂuorescent
protein under confocal microscope (Fig. 2a). Signiﬁcant amount
of EGFP was only expressed in cells supplemented with sTyr,
while minimal background was observed without sTyr (Fig. 2a).
In addition to cell imaging, ﬂow cytometry was used to quantify
the amber suppression efﬁciency based on the ﬂuorescence
intensity (Supplementary Fig. 2). As shown in Fig. 2b, when the
suppression efﬁciency of the wild-type EcTyrRS was assigned as

100%, the efﬁciency of sTyrRS is about 68%, which is signiﬁcantly
higher (P < 0.01) than a well-established EcTyrRS mutant, AzFRS
(for the incorporation of p-azido-L-phenylalanine; AzF38,39). On
the other hand, the evolved sTyrRS did show a higher background signal than AzFRS when noncanonical amino acid
(ncAA) was not available (Fig. 2b). We also conducted protein
expression of an EGFP mutant that contains two amber codons in
its encoding gene at positions Y40 and N150 (on plasmid pEGFPdouble). As shown in Supplementary Fig. 3, EGFP ﬂuorescence
was only detected when 1 mM sTyr was included in the cell
culture media. The expression level of EGFP-double (Supplementary Fig. 3) was apparently lower than that of EGFP containing one amber codon (Fig. 2a).
Finally, the ﬁdelity of the evolved sTyrRS was quantiﬁed by
mass spectrometry. Since the sulfoester bond in sTyr is labile and
can readily decompose to yield Tyr under mass spectrometry
conditions5, it would be impossible to directly analyze the ratio of
sTyr versus mis-incorporated Tyr in the target protein. To solve
this problem, we synthesized and used di-deuterium labeled sTyr
(sTyr-D2; Supplementary Fig. 4a) in the incorporation study. To
reduce the cost of this experiment, we used a mixture of sTyr-D2
and unlabeled sTyr instead of pure sTyr-D2. The mixture
contained sTyr-D2 at 24.2 ± 0.3% (mol%) by mass spectrometry
quantiﬁcation. To conduct the analysis, the EGFP-Tyr40TAG was
expressed in 293T cells in the presence of the sTyr-D2/sTyr
mixture at 1 mM. Since the cell culture media (DMEM with 10%
FBS) contains at least 0.4 mM Tyr (a component of DMEM), we
should see a signiﬁcant dilution of the deuterium label at position
40 of EGFP if the evolved sTyrRS incorporates Tyr at a
substantial level. The mutant protein was puriﬁed by Ni afﬁnity
resin followed by SDS-PAGE (Supplementary Fig. 4b), then
subjected to trypsin digest. The resulting peptides were analyzed
by a Synapt G2S HDMS quadrupole time of ﬂight (Q-TOF)
hybrid mass spectrometer. The peptide fragment that contained
the position of incorporation showed the percentage of Tyr-D2 at
position 40 as 24.3 ± 1.3%, which is in close agreement with the
percentage of di-deuterium labeled sTyr supplemented to the cell
culture media (Supplementary Fig. 5). The data excluded
misincorporation of unlabeled Tyr from the cell culture media
at position 40 of EGFP in the presence of sTyr. Otherwise, it
would lead to the dilution effect and lower the percentage of
deuterium labeled peptide. While some background incorporation of Tyr was observed in the absence of sTyr (Fig. 2a), the
above studies demonstrate that the evolved sTyrRS can
aminoacylate amber suppresser tRNA with high efﬁciency and
ﬁdelity in the presence of sTyr in mammalian cells.
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Fig. 2 Evaluation of sTyrRS in mammalian cells. a Confocal images of 293T cells expressing the evolved sTyrRS and an EGFP mutant that contained an
amber mutation at position Tyr40. The left panel shows ﬂuorescent images, the middle panel shows brightﬁeld images, and the right panel shows
composite images of bright-ﬁeld and ﬂuorescent images. Scale bars, 50 μm. b Flow cytometry analyses of 293T cells expressing the evolved sTyrRS,
AzFRS, and wild-type EcTyrRS, each with the EGFP-Y40TAG mutant. The normalized ﬂuorescence was calculated by multiplying the mean ﬂuorescence
intensity by the percentage of ﬂuorescent cells in ﬂow cytometry analyses in the absence (open bar) or presence (ﬁlled orange bar) of ncAA. b Data are
plotted as the mean ± s.d. from n = 3 independent experiments. The raw data of ﬂow cytometry experiments are shown in Supplementary Fig. 2. b Source
data are provided as a Source data ﬁle.
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Structural insights into the evolved sTyrRS. To understand key
changes that shift the substrate speciﬁcity of the evolved sTyrRS,
we conducted structural study of its amino acid activation
domain (a.a. 1-322). The domain was overexpressed and puriﬁed
as a fusion protein with an N-terminal 6xHis-SUMO tag, which
was removed by treatment with the SUMO protease prior to
crystallization. We obtained and reﬁned the crystal structure of
the evolved sTyrRS in complex with sTyr at 1.78 Å resolution.
The protein formed a homodimer, the same as the wild-type
EcTyrRS (Supplementary Fig. 6a)29. In comparison to the structure of the wild-type EcTyrRS in complex with L-Tyr (PDB ID:
1X8X), the introduction of the L71V and D182G mutations in the
evolved sTyrRS led to an expanded active site to accommodate
the larger side chain of sTyr (Fig. 3a, b). In addition, the D182G
mutation eliminates the potential repulsion between the negatively charged carboxylate group of Asp and the sulfate group of
sTyr. This mutation also contributed to the lowered afﬁnity of the
evolved sTyrRS towards Tyr, due to the abolishment of a stabilizing hydrogen bond (Fig. 3d). A third mutation, W129F, contributes to the substantially lower background activity of the c2
variant towards Tyr. This is likely due to the smaller size of the
Phe side chain, which further contributes to the enlarged active
site (Fig. 3a). A close inspection of ligand binding revealed that
the phenol ring of the sTyr tilted around 26° away from that of
the Tyr (Supplementary Fig. 6f). This movement enabled the
4

formation of a hydrogen bond between the sulfate group and the
hydroxyl group of Tyr37 residue (Fig. 3c). Since this Tyr is also
critical for the binding of Tyr substrate in the active site of the
wild-type EcTyrRS (Fig. 3d), its retention likely played a major
role in the background activity of the evolved sTyrRS towards Tyr
when sTyr was not available. Another key interaction that
anchors the sulfate group is a hydrogen bond with the side chain
of Asn126 (Fig. 3c), which does not participate in substrate
binding in the wild-type EcTyrRS. Finally, the three mutations in
the evolved sTyrRS did not interrupt the three hydrogen bonds
that are essential for recognizing the α-amino group of the substrate (Supplementary Fig. 6d and 6e).
Functional incorporation of sTyr in CXCR4 protein by
sTyrRS. To demonstrate that sTyr can be functionally and
selectively incorporated into naturally sulfated positions of
target proteins in live mammalian cells, we conducted studies of
chemokine receptor CXCR4. The activation of CXCR4 by its
cognate chemokine ligand, stromal cell-derived factor 1 (SDF-1;
also known as CXCL12), triggers multiple downstream signal
transduction pathways that regulate intracellular calcium ﬂux,
chemotaxis, transcription, and cell survival. It is known
that sulfation of tyrosine residues (Y7, Y12, and Y21, Supplementary Fig. 7a) near the N-terminus of CXCR4 is required
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for optimal binding with SDF-1. According to previously reports,
the relative importance of the three sulfation sites of CXCR4 for
its ligand binding and activation is Tyr21 > Tyr12 > Tyr740,41.
Therefore, we decided to focus on the Tyr21 site of CXCR4 in
this work.
The incorporation of sTyr at the 21 position of CXCR4 was
examined using plasmids psTyrRS and pCXCR4(21TAG)-EGFP,
which encoded a CXCR4 mutant as a fusion protein with EGFP
on its C terminus. The suppression of the amber mutation in
CXCR4 led to the expression of EGFP in 293 T cells of which the
ﬂuorescence was monitored by ﬂow cytometry. In the presence of
sTyr, a twofold increase in ﬂuorescence was observed, which was
43.5% of the suppression efﬁciency when the wild-type EcTyrRS
was used (Supplementary Fig. 7b). To further conﬁrm that sTyr
was speciﬁcally incorporated at position 21, we also conducted
western blot analyses. As a membrane protein, CXCR4 showed
anomalous migration in SDS-PAGE42. To circumvent this issue,
we fused the DNA sequence that encodes the ﬁrst 38 residues of
CXCR4 with the EGFP-encoding gene containing a 6xHis tag on
its C terminus. The resulting pCXCR4(N38-FF 21TAG)-EGFP
plasmid also included Y7F, Y12F and an amber mutation at the
Tyr21 position. The Y7F and Y12F mutations eliminate any
possibility of TPST-catalyzed sulfation at these two sites and
makes the position 21 the only site that contains sTyr residue
through the sTyrRS-mediated incorporation, which simpliﬁes the
interpretation of western blot experiments with the anti-sTyr
antibody.
Probing lysates of 293T cells transfected with plasmids
pCXCR4(N38-FF 21TAG)-EGFP and psTyrRS with antihistidine tag antibody showed the higher expression level of a
protein corresponding to the size of CXCR4(N38 FF 21sTyr)EGFP when sTyr (1 mM) was provided to cells (Fig. 4a,
Supplementary Fig. 7c). Protein with His-tag was partially
puriﬁed using Ni resin (Supplementary Fig. 7d) and further
subject to western blot using both anti-histidine tag and anti-sTyr
antibodies (Fig. 4b). The sample from cells cultured with sTyr
showed positive signals with both antibodies. In contrast, the
sample from cells cultured without sTyr was only positive with
the anti-histidine antibody (Fig. 4b). As controls, puriﬁed CXCR4
(N38)-EGFP and CXCR4(N38-FFF)-EGFP, which had Tyr to Phe
mutations at all three positions, were also only detected by antihistidine tag antibody. Since the CXCR4(N38)-EGFP variants
were cytosolic, they did not transit through trans-Golgi network
where PTSTs reside and were not sulfated by the endogenous

protein sulfation machinery. Results of the above western blot
analyses conﬁrmed that sTyr was successfully incorporated in
response to the amber codon at position 21.
Next, we examined the function of translationally incorporated
sTyr at position 21 of CXCR4 using the calcium mobilization
assay. To eliminate the background signal caused by the
expression of endogenous CXCR4 in 293T cell line, we generated
a CXCR4-knockout cell line, 293T-ΔCXCR4 (C4), using CRISPR/
Cas method (see details in Supplemental Information)43. An
approximate 90% reduction of signal in calcium mobilization
assay was observed when C4 was treated with SDF-1 (Fig. 4c).
The signal in C4 was restored when the wild-type CXCR4 was
expressed from plasmid pCXCR4 and reduced back to near basal
level when a CXCR4-FFF mutant, which had Y7F, Y12F, and
Y21F mutations, was expressed (Fig. 4c). The tyrosine to
phenylalanine mutation has been widely used to remove sulfation
sites with minimal structural perturbation to target proteins9,11,44,45. To speciﬁcally probe the functional incorporation
of sTyr at position 21 in CXCR4, calcium mobilization in C4 cells
expressing CXCR4(FF TAG) (Y7F, Y12F, and Y21TAG) was
studied. As shown in Fig. 4c, SDF-1-triggered calcium mobilization was observed when CXCR4(FF TAG) was co-expressed with
the evolved sTyrRS in the presence of 1 mM sTyr. On the other
hand, over twofold lower and near basal level calcium mobilization was detected when CXCR4(FF TAG) was expressed in the
absence of the evolved sTyrRS (p < 0.05). The above results
validated a previous ﬁnding40,41 that sulfation at Tyr21 position
of CXCR4 is important for the activation of this receptor by its
chemokine ligand. Overall, our work demonstrated that genetically incorporated sTyr can reconstitute the function of CXCR4
and is suitable for cellular studies.
Discussion
By using yeast as the selection host, we have identiﬁed EcTyrRS
mutants that were able to genetically encode sTyr in both yeast
and mammalian cells. To overcome the problem of low transformation efﬁciency with circular DNA, linear DNA fragments
were transformed into yeast cells and assembled into EcTyrRS
library through the host’s homologous recombination machinery.
We could regularly obtain libraries of 107 diversity, which
is comparable to the capacity of the commonly used E. coli
platform. This would facilitate current efforts on engineering
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aaRSs for genetic incorporation of ncAAs into proteins in
eukaryotic cells.
The evolved sTyrRS displayed good efﬁciency in comparison to
its parental wild-type EcTyrRS and to a well-established AzFRS.
While a side-by-side evaluation has not been conducted with
evolved sTyrRSs from this and Chatterjee’s work28, comparable
activities are expected since they have similar mutations,
including Leu71Val and Asp182Gly. The Chatterjee’s sTyrRS
does not have the Trp129Phe mutation as the sTyrRS in this
report, but does contain a unique Leu186Met mutation. Residue
Leu186 sits on the same α helix as residue Asp182, but is further
away from the ligand in the wild-type EcTyrRS (Supplementary
Fig. 8a). In the expanded substrate pocket of our mutant sTyrRS,
Leu186 resides on the active site surface and mutation at this site,
similar to our Trp129Phe mutation, may ﬁne tune the sTyr
binding pocket (Supplementary Fig. 8b). Incorporation of the
Leu186Met or other mutations at this position of our sTyrRS
mutant may lead to further improvement of properties. The
evolved sTyrRS displayed certain level of background. However,
mis-incorporation of Tyr was not observed in the presence of
sTyr, which suggests that the evolved sTyrRS is more active on
sTyr than Tyr. This notion was conﬁrmed by the results of
in vitro enzyme assays. Our structural study showed that Tyr37
could form a hydrogen bond with either sTyr or Tyr. It therefore
can potentially contribute to the background activity of the
evolved sTyrRS towards Tyr. Further mutagenesis that weakens
hydrogen bonding between Tyr37 and the undesirable Tyr substrate can likely lead to sTyrRS variants with higher speciﬁcity.
We are currently conducting molecular dynamics simulations
using the obtained sTyrRS structure to identify potential sites for
modiﬁcation. Our ﬁndings will be reported in due course.
In a proof of concept study using the CXCR4/SDF-1 axis as the
model system, we demonstrated that the genetically incorporated
sTyr could be readily used to study the role of sTyr in the activation of chemokine receptors in live mammalian cells. While a
single sulfation site (sTyr21) was the focus of this work to
demonstrate the utility of genetic encoding of sTyr in live-cell
studies, it is possible to investigate multiple sulfation sites
simultaneously in the future. However, caution is recommended
in such studies since the efﬁciency of genetic incorporation of
sTyr is likely decreased due to the need to suppress multiple
amber codons within the same transcript. Since many G proteincoupled receptors, including chemokine receptors, are sulfated, it
is crucial to understand whether and how sulfation events affect
receptor-ligand interactions. The system established in this work
is a useful tool to facilitate the study of protein sulfationassociated eukaryotic signaling processes and the development of
diagnostic and therapeutic agents targeting protein sulfation.
Furthermore, the genetic incorporation of sTyr is expected to
enable facile productions of therapeutic proteins containing tyrosine sulfation, which has been reported as a key posttranslational modiﬁcation to boost the efﬁcacy46.
Methods
Reagents and media. All commercial chemicals are of reagent grade or higher. All
solutions were prepared in deionized water that was further treated by Barnstead
Nanopure® ultrapure water puriﬁcation system (Thermo Fisher Scientiﬁc). Preparation of LB medium and YPD medium followed the reported recipe. Yeast
selection media contained yeast nitrogen base without amino acids (DifcoTM,
6.7 g/L), glucose (10 g/L), and appropriate drop out (DO) supplements (Clonetech).
The pH values of all media were adjusted to 7.0. Agar plates were prepared by the
addition of Difco agar (15 g/L) to the liquid medium. Antibiotics were added where
appropriate to the following ﬁnal concentrations: kanamycin (50 mg/L), ampicillin
(100 mg/L). IPTG stock solution was added as necessary to the indicated ﬁnal
concentration. Solutions of antibiotics and IPTG were ﬁltered through 0.22 μm
sterile membrane ﬁlters. Sulfotyrosine was synthesized by following our previously
published procedure47. In brief, triﬂuoroacetic acid (50 mL) and L-tyrosine (10 g,
55.6 mmol) were added into a dry round-bottom ﬂask with a magnetic stir bar at
6

−10 °C. While stirring under nitrogen protection, 5 mL (75.2 mmol) of chlorosulfonic acid was added over 2 min. The reaction was stirred for an additional 5
min, quenched by the addition of ethanol (3 mL), and stirred for another 2 min at
room temperature. Sulfotyrosine was precipitated with ether (175 mL), ﬁltered, and
washed three times with ether (75 mL per wash). The product was dried under
vacuum to remove residual ether.
Mammalian cell experiments. Mammalian cells were maintained in DMEM
(Gibco™) media supplemented with 10% FBS (v/v) at 37 °C in a humidiﬁed
atmosphere of 5% CO2 (v/v). Transfection was conducted at 70–80% cell conﬂuency using Lipofectamine 2000 (Life Technologies) according to the manufacturer’s protocol. For puriﬁcation of protein with 6xHis tag, cells from a T-25 or
T-75 ﬂask were detached and lysed in RIPA lysis and extraction buffer (Thermo
Scientiﬁc) with protease inhibitor cocktail (EDTA-free, Thermo Scientiﬁc). Following centrifugation at 21,000 × g for 30 min at 4 °C, the supernatant was collected
and dialyzed into puriﬁcation buffer, which contained potassium phosphate (25
mM, pH 7.5), NaCl (200 mM), and imidazole (10 mM). The tagged protein was
puriﬁed using Ni Sepharose 6 Fast Flow resin (GE Healthcare) by following the
manufacturer’s protocol.
Biochemical analysis. Protein concentrations were determined by using the Quick
StartTM Bradford protein assay kit (Bio-Rad Laboratories). Western blot experiments started with sample separation by SDS-PAGE. Proteins were then transferred onto a nitrocellulose membrane using mini trans-blot cell (Bio-Rad
Laboratories) at 100 V for 1 h. The membranes were blocked overnight at 4 °C,
then incubated with primary and secondary antibodies for 1 h each: mouse anti6xHis tag monoclonal antibody (1:3000, MCA1396, Bio-Rad Laboratories), mouse
anti-sulfotyrosine antibody clone sulfo-1C-A2 (1:1000, 05-1100, MilliporeSigma),
and HRP conjugated goat anti-mouse IgG (1:1000, 1706516, BioRad Laboratories).
Blots were developed using Opti-4CN detection kit (BioRad Laboratories) and
imaged using Gel Doc XR+ system. A Biotek Synergy HTX plate reader was used
in absorbance, ﬂuorescence, and kinetics measurements.
Strains and plasmids. E. coli GeneHogs® (Thermo Fisher Scientiﬁc) was used for
routine cloning and plasmid propagation. Plasmid construction was performed
using Gibson Assembly method48. E. coli BL21(DE3) (New England Biolabs) was
used for protein expression and puriﬁcation. S. cerevisiae strain MaV203 (MATα;
leu2-3,112; trp1-109; his3Δ200; ade2-101; cyh2R; cyh1R; gal4Δ; gal80Δ; GAL1::lacZ;
HIS3UASGAL1::HIS3@LYS2; SPAL10UASGAL1::URA3) (Thermo Fisher Scientiﬁc) was
used for yeast library construction and selection. Standard protocols were followed
for the puriﬁcation and analysis of plasmid DNA49. PCR ampliﬁcations were
carried out using KOD Hot Start DNA polymerase (MilliporeSigma) by following
the manufacturer’s protocol. Other molecular cloning reagents were purchased
from New England Biolabs. Primer synthesis and DNA sequencing services were
provided by Euroﬁns MWG Operon. Primers used in this study are listed in
Supplementary Table 1. Plasmids used and constructed in this study are listed in
Supplementary Table 2. All plasmids are available from corresponding authors
upon reasonable request.
Plasmid pyeGFP-N149TAG. This 7.3-kb plasmid is a pGAD-derived plasmid that
contains a mutant yeast enhanced green ﬂuorescent protein (yeGFP) gene behind
the yeast glyceraldehyde-3-phosphate dehydrogenase promoter (TDH3). Promoter
TDH3 was ampliﬁed from the genomic DNA of S. cerevisiae strain BY4742. Gene
of yeGFP was ampliﬁed as two fragments from plasmid pDZ27650 (Addgene
35194). The N149TAG mutation was introduced using primers for the ampliﬁcation of the second fragment. Obtained PCR products were puriﬁed by DNA
electrophoresis followed by gel isolation, then assembled into pGAD vector that
was prepared by removing a mutant GAL4 gene from pGADGAL432 by SphI and
AgeI digestion.
Plasmid pET30b-sTyrRSs. These 6.7-kb plasmids are pET30b-derived plasmids
that encode candidate sTyrRSs with a C-terminus 6xHis tag. DNA fragments
encoding candidate sTyrRSs were ampliﬁed without the stop codon using isolated
library plasmids as templates. PCR products were assembled into pET30b
(Novagen) vector that was linearized by digestion with NdeI and XhoI.
Plasmid psTyrRS and pEcTyrRS. These 7.4-kb plasmids are pcDNA3.1-derived
plasmids that contain one copy of the amber suppressor B. subtilis tyrosyl-tRNA
behind a human U6 promoter and an indicated tRNA synthetase-encoding gene
behind a CMV promoter. The construction of the plasmid was completed by
replacing an AzFRS-encoding gene in pcDNA3.1-AzFRS51 with the desirable DNA
sequence. Fragments encoding the wild-type EcTyrRS or the evolved sTyrRS were
ampliﬁed from E. coli genomic DNA or isolated library plasmid. Puriﬁed PCR
product was assembled into a 6.2-kb DNA fragment from the digestion of
pcDNA3.1-AzFRS by HindIII and ApaI.
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Plasmid pEGFP-double. The 4.3 kb plasmid is derived from pEGFP37 by replacing
a 0.8 kb DNA fragment, which has ﬂanking XbaI and ApaI sites, with a PCR
product that contains the N150TAG mutation.
Plasmid pCXCR4 and derivatives. The 7.2-kb pCXCR4 plasmid is derived from
pcDNA3.1 by replacing the AzFRS-encoding gene in pcDNA3.1-AzFRS with
human CXCR4 variant 2. DNA fragment encoding human CXCR4 was ampliﬁed
from pCEP4-FLAG-CXCR452 (Addgene 98947). Puriﬁed PCR product was
assembled into a 6.2-kb DNA fragment from the digestion of pcDNA3.1-AzFRS by
HindIII and ApaI. Mutations were introduced into the CXCR4 gene of pCXCR4
plasmid by mutagenic PCR.
Plasmid pCXCR4-EGFP and derivatives. The 8.0-kb pCXCR4-EGFP plasmid is
derived from pcDNA3.1 by replacing the AzFRS-encoding gene in pcDNA3.1AzFRS with a fusion gene between the human CXCR4 variant 2 and EGFP. DNA
fragments encoding human CXCR4 without the stop codon and mammalian EGFP
were ampliﬁed from plasmid pCXCR4 and pEGFP, respectively. Puriﬁed PCR
products were assembled into a 6.2-kb DNA fragment from the digestion of
pcDNA3.1-AzFRS by HindIII and ApaI. Mutations were introduced into the
CXCR4 gene of pCXCR4-EGFP plasmid by mutagenic PCR.
Plasmid pCXCR4(N38)-EGFP and derivatives. The 7.0-kb pCXCR4(N38)-EGFP
plasmid was constructed in a similar way to pCXCR4-EGFP, except the PCR
product of DNA that encodes the ﬁrst 38 amino acid of CXCR4 (CXCR4(N38))
was used in the Gibson assembly reaction. Obtained plasmid expressed a fusion
protein CXCR4(N38)-EGFP. Mutations were introduced into the CXCR4(N38)
sequence of pCXCR4(N38)-EGFP plasmid by mutagenic PCR.
Plasmid pET-6xHis-SUMO-sTyrRS. The plasmid was derived from a protein
expression vector, pET-6xHis-SUMO, which was constructed in Dr. Limei Zhang’s
lab. DNA sequence encoding residues 1–322 of the evolved sTyrRS was ampliﬁed
from psTyrRS. Puriﬁed PCR product was assembled into pET-6His-SUMO vector
that was linearized by BamHI and XhoI.
Library construction and selection. To construct the EcTyrRS library, four sites
(Y37, L71, W129, and D182) were targeted for randomization using the NNK
codon (N = A, C, T, or G, K = T or G) by mutagenic PCR. Four DNA fragments,
each contained a single mutation site, were ampliﬁed using primers (Supplementary Table 1). Puriﬁed PCR products were assembled by overlapping PCRs53 to
produce a single DNA fragment that contained a 64-bp arm on each end that is
homologous to the cloning vector, pEcTyrRS-lib32, which was linearized by
digestion with EcoRI and BamHI. The EcTyrRS library was generated by yeast
homologous cloning method54 as follows. To prepare electrocompetent yeast cells,
single colony of MaV203/pGADGAL4 maintained on SD-Leu agar plate was used
to start a seed culture, which was introduced into 100 mL fresh YPD media to reach
a starting OD600 of 0.3. Following cultivation at 30 °C for 6 h, cells were collected,
washed, then resuspended in electroporation buffer(1 M sorbitol and 1 mM CaCl2)
to reach a ﬁnal volume of 1 mL. The PCR product (30 μg) and linearized vector (10
μg) were mixed with the prepared competent cells. Electroporation was done at 2.5
kV and 25 μF in electroporation cuvettes (2 mm). Following electroporation, cells
were recovered in 20 mL of sorbitol (1 M) and YPD mixture (1:1, v/v) at 30 °C for
1 h. Recovered cells were washed to remove extra nutrients, then cultured in 400
mL of SD-Leu-Trp media. A library size of 1 × 107 diversity was obtained.
Library selection was conducted by adapting a previously established procedure
(Supplementary Fig. 1c)32 as follows. First, a positive selection was conducted by
culturing cells on plates without uracil to identify EcTyrRS variants that can
efﬁciently aminoacylate the amber suppressor tRNA with sTyr. A total of 1 × 107
cells was applied to the SD-Leu-Trp-Ura plates supplemented with 1 mM sTyr.
Following incubation at 30 °C for 5 days, ~1000 colonies formed. These colonies
were collected from the agar surface using SD-Leu-Trp media, then washed three
times prior to the negative selection. In the negative selection, cells were plated on
SD-Leu-Trp media plates containing 5-ﬂuoroorotic acid (5-FOA) at 0.1%, but no
sTyr. EcTyrRS variants that can charge the amber suppressor EctRNACUA with any
one of the 20 natural amino acids led to GAL4-activated expression of URA3,
which converts 5-FOA into a cytotoxic product and causes cell death. A total of 1 ×
104 cells was subjected to the negative selection, and around 100 colonies formed
after incubation at 30 °C for three days. Single colonies picked from the selection
plates were resuspended in 100 μL of SD-Leu-Trp-Ura media. A 2 μL cell
resuspension was applied to SD-Leu-Trp-Ura, SD-Leu-Trp-Ura+1 mM sTyr, and
SD-Leu-Trp+0.1% FOA plates to further verify the phenotypes.
Fluorescence analysis of yeast culture. Yeast MaV203 strain harboring plasmid
pyeGFP-N149TAG and a plasmid that encoded a sTyrRS variant was cultured in
SD-Leu-Trp media without or with sTyr (1 or 5 mM) at 30 °C for 12 h following a
5% inoculation from a seed culture. Cells were then collected, washed, and then
resuspended in PBS (pH 7.4). Cell density was determined by measuring OD600nm.
The ﬂuorescence of yeGFP was monitored at λEx = 485 nm and λEm = 528 nm.
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Values of ﬂuorescence intensity were normalized to cell growth. Reported data are
the average of three measurements with standard deviations.
Confocal microscopy. 293T cells (1 × 105) seeded in a single well of a 24-well plate
were grown for 24 h, then transfected with plasmids psTyrRS (0.8 μg) and pEGFP
(0.8 μg) in 2 μL of Lipofectamine. Transfected cells were cultured for an additional
24 h in 0.5 mL of media without or with sTyr (1 mM). Cells were then washed with
0.5 mL of warm DMEM base medium, ﬁxed with 4% paraformaldehyde (w/v) for
15 min. Following removal of the ﬁxation reagent by washing with 3 × 0.5 mL
DPBS, cells were visualized by an Inverted (Olympus IX 81) confocal microscope.
Flow cytometry analysis. For the quantiﬁcation of amber suppression efﬁciency
by sTyrRS, 293T cells (1 × 105) seeded in a single well of a 24-well plate were grown
for 24 h, then transfected with one plasmid that encodes a tRNA synthetase (0.8 μg
of psTyrRS, AZFRS, or EcTyrRS) and pEGFP (0.8 μg) in 2 μL of Lipofectamine.
Transfected cells were cultured for an additional 24 h in 0.5 mL of media without
or with ncAA (1 mM of sTyr or AzF). Cells were detached with 0.3 mL of Trypsin/
EDTA (0.05%, Thermo Fisher Scientiﬁc), washed once with 1 mL DPBS, and
collected by centrifugation at 300 × g for 5 min. Collected cells were resuspended in
0.5 mL 4% paraformaldehyde (w/v) and incubated for 20 min at room temperature.
Following removal of the ﬁxation reagent by centrifugation, cells were resuspended
in 0.5 mL DPBS and kept on ice until analysis. Fluorescence of cells was measured
using a Beckman Coulter CytoFLEX ﬂow cytometer. A total of 30,000 cells were
analyzed for each sample. Data were analyzed using FlowJo. Reported data are the
average measurement of three samples with standard deviations. Flow cytometry
analysis of sTyr incorporation into CXCR4(21TAG)-EGFP followed the similar
method.
In vitro tRNA synthetase assay. For protein puriﬁcation, plasmid pET30bsTyrRS was transformed into protein expression host E. coli BL21(DE3). A 1 mL
overnight seed culture was introduced into 100 mL of fresh LB medium containing
kanamycin. When cell growth reached exponential phase (OD600 ~ 0.4–0.6),
protein expression was induced with IPTG (0.5 mM). Cells were cultured continuously at room temperature for an additional 12 h prior to harvesting. Collected
cells were lysed by sonication and tRNA synthetase with C-terminal 6xHis tag was
puriﬁed on Ni resin by following the manufacturer’s protocol, except for replacing
phosphate buffer with Tris-HCl buffer (25 mM, pH 7.5). Protein concentration was
measured by Bradford assay and purity was analyzed by SDS-PAGE.
For tRNA substrate preparation, the E. coli tyrosyl-tRNA substrate with CUA
anticodon loop (EctRNACUA) was prepared by in vitro transcription using the
MEGAscript® Kit (Life Technologies). A T7 promoter sequence (5′TAATACGACTCACTATAGGG) was added to the 5′ end of the forward primer.
Primers T7-Tyr-F and T7-Tyr-R were used to amplify the EctRNACUA from
pEcTyrRS-lib template. A 20 μL reaction was set up with 0.2 μg PCR product, 8 μL
NTPs mixture (18.75 mM each of ATP, CTP, GTP, and UTP), 2 μL enzyme mix,
and 2 μL reaction buffer. The reaction was incubated at 37 °C for 12 h. The in vitro
transcription was stopped by the addition of 150 μL ammonium acetate stop
solution, then extracted with 150 μL phenol:chloroform:isoamyl alcohol (25:24:1).
Collected aqueous phase was precipitated with an equal volume of isopropanol.
Obtained tRNA pellet was dissolved in 50 μL nuclease-free water and the
concentration was determined by A260. The tRNA was folded prior to
aminoacylation reactions by heating at 70 °C for 10 min, followed by the
addition of MgCl2 to 10 mM, then slow cooling by incubation at room temperature
for 5 min.
For tRNA synthetase assay, standard in vitro aminoacylation assays were
performed using EnzChek® Pyrophosphate Assay Kit (Thermo Fisher Scientiﬁc) to
continuously monitor the release of PPi36,55. The assay mixture contained ATP
(0.1 mM), tRNA (10 μM), tRNA synthetase (5 μM), tyrosine or sulfotyrosine at
speciﬁed concentrations, 2-amino-6-mercapto-7-methylpurine ribonucleoside
(MESG, 0.2 mM), purine nucleoside phosphorylase (1 U/mL), and inorganic
pyrophosphatase (0.03 U/mL) in a reaction buffer of HEPES (50 mM, pH 7.5) with
MgCl2 (10 mM), KCl (50 mM), and dithiothreitol (1 mM). Assays were carried out
in 384-well format at room temperature by monitoring the absorbance change at
360 nm. Each reaction was initiated by the addition of an amino acid substrate.
Control reactions without a substrate were performed. The standard curve of
A360nm vs. PPi concentrations was constructed and used for the calculation of
tRNA synthetase activities.
Mass spectrometry analysis of sTyr incorporation in mammalian cells. For
protein puriﬁcation, a T-75 ﬂask was seeded with 3.0 × 106 293T cells. Following
24 h of growth, cells were transfected with psTyrRS (19.2 μg) and pEGFP (19.2 μg)
in 48 μL of Lipofectamine. Cells were cultured for an additional 24 h in media
containing 1 mM of sTyr-D2/sTyr mixture. Protein EGFP-Tyr40sTyr was puriﬁed
from collected cells using Ni resin and further resolved from impurity by SDSPAGE (Supplementary Fig. 4b). The band of EGFP-Tyr40sTyr was excised,
washed, and treated with trypsin overnight at 37 °C. Tryptic peptides were
extracted from the gel pieces, dried down, and re-dissolved in 25 μL of aqueous
solution of acetonitrile (2.5%) and formic acid (0.1%).
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For mass spectrometry analysis, all experiments were conducted using a Synapt
G2S HDMS Q-TOF hybrid mass spectrometer (Waters, Manchester, UK) equipped
with a nanoAcquity Ultra Performance LC (Waters, Manchester, UK) and an
Acquity UPLC M-Class Peptide BEH C18 Column. Separation of peptides was
performed using an acetonitrile gradient (0-85% ACN over 35 minutes) in the
presence of 0.1% formic acid with the ﬂow rate of 6 μL/min. The spectral
acquisition was conducted in MassLynx 4.1 (Waters, Manchester, UK) with data
handling and integration performed using IGOR Pro 6.3 (WaveMetrics, Lake
Oswego, OR, USA). Deuterated percentages were calculated using peak area
integrations of the MH and [(MH + 2) + MD] peaks and predicted isotope
abundances of the target molecules.
MH  ðpredicted isotope abunanceÞ  ½ðMH þ 2Þ þ MD  ¼ MD peak area
MD
 100 ¼ Deuterated Percentage
MH

ð1Þ
ð2Þ

Crystallization of sTyrRS. For protein puriﬁcation, plasmid pET-6xHis-SUMOsTyrRS was transformed into protein expression host E. coli BL21(DE3). Cell
culturing, induction of protein expression, and puriﬁcation of the tagged protein
followed the same protocol as the puriﬁcation of full-length sTyrRS. The Nterminal 6xHis-SUMO tag was removed by treatment with Ulp1. Following protease digest, the mixture was passed through Ni resin and the ﬂow-through fraction, which contained sTyrRS (1–322), was collected. Obtained protein was
dialyzed into the desalting buffer that contained NaCl (50 mM) and 2mercaptoethanol (5 mM) in Tris-HCl buffer (20 mM, pH 7.5) using 10DG
desalting columns (Bio-Rad Laboratories). Protein was further puriﬁed by gel ﬁltration using a Superdex 200 column (GE Healthcare Life Sciences) at a ﬂow rate of
2 mL/min. Collected fractions were concentrated to 10 mg/mL, ﬂash frozen in
liquid nitrogen, then stored at −80 °C until crystallization trials.
The sTyrRS1-322−sulfotyrosine complex was crystalized by sitting drop vapor
diffusion at 15 °C. Sulfotyrosine was added to the puriﬁed sTyrRS protein (a.a.
1–322, 9 mg/mL) to a ﬁnal concentration of 2 mM. Obtained protein solution was
then mixed at a 2:1 ratio (v/v) with the reservoir solution containing ammonium
sulfate (2.2 M) and PEG 400 (2.5–3%, v/v) in HEPES buffer (0.1 M, pH 7.5). The
crystals typically reached the maximum size by three days. Fomblin® Y LVAC 16/6
(MilliporeSigma) was used as a cryoprotectant during crystal harvesting.
The X-Ray diffraction data were collected at Beamline 12-2 of the Stanford
Synchrotron Radiation Lightsource (SSRL), with a 6 M Pixel Array Detector. A set
of 1440 diffraction images were collected at 12660.4 eV with an oscillation angle of
0.25°. Diffraction data were integrated with the XDS program and subsequently
processed using the CCP4 suite56,57. The crystal structure of Escherichia coli TyrRS
(PDB ID: 2YXN) was used as the initial model for phase determination58. Further
structural reﬁnement was carried out using PHENIX, REFMAC5 and COOT59–61.
The structural validation was performed by MolProbity62. The PyMol (Schrödinger
Inc.) program was used for structural analysis and for generating ﬁgures. The
diffraction data and reﬁnement statistics are summarized in Supplementary
Table 3. The 2Fc-Fo electron density map (3.0 σ) and Fo-Fc omit electron density
map (3.0 σ) are shown in Supplementary Fig. 6b and 6c. The atomic coordinates
and experimental data (code 6WN2) have been deposited in the Protein Data Bank
(www.wwpdb.org).

at room temperature protected from light, media was replaced with fresh DMEM
and cells were incubated at room temperature protected from light for another
45 min. Cells were washed with 100 μL DPBS once, then immersed in 100 μL fresh
DPBS and ready for assay. Calcium mobilization was measured using excitation at
485 nm and emission at 528 nm. Fluorescence of cells was monitor for 2 min prior
to the addition of SDF-1 (20 nM) and for 4 min after the stimulation. The calcium
response was calculated as the percentage of ﬂuorescence change over baseline.
Data are expressed as the average of three measurements with standard deviation.
Statistics and reproducibility. Standard deviations and Student’s t test were
performed using Microsoft Excel 365 software. Similar results were obtained from
three independent experiments.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Data availability
All data generated or analyzed during this study are included in this article and its
Supplementary Information. All relevant data are available from the authors upon
reasonable request. Source data are provided with this paper. Crystal structure of sTyrRS
in complex with sTyr is deposited in Protein Data Bank (PDB ID: 6WN2. Crystal
structures of E. coli tyrosyl-tRNA synthetase (TyrRS) in complex with L-tyrosine (PDB
ID: 1X8X) and E. coli TyrRS (PDB ID: 2YXN) are accessed from Protein Data
Bank. Source data are provided with this paper.
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